5-Lipoxygenase DNA Methylation and mRNA Content in the Brain and Heart of Young and Old Mice

被引:16
作者
Dzitoyeva, Svetlana [1 ]
Imbesi, Marta [1 ]
Ng, Louisa W. [1 ]
Manev, Hari [1 ]
机构
[1] Univ Illinois, Dept Psychiat, Inst Psychiat, Chicago, IL 60612 USA
关键词
FOCAL CEREBRAL-ISCHEMIA; PHOSPHOLIPASE A(2); LEUKOTRIENE B-4; LIPOXIN A(4); EXPRESSION; PROTEIN; PATHWAY; PHOSPHORYLATION; DEMETHYLATION; PIOGLITAZONE;
D O I
10.1155/2009/209596
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The expression of 5-lipoxygenase (5-LOX) is affected by aging and regulated by epigenetic mechanisms including DNA methylation. We used methylation-sensitive restriction endonucleases (AciI, BstUI, HpaII, and HinP1I) to assess 5-LOX DNA methylation in brain and heart tissue samples from young (2 months) and old (22 months) mice. We also measured mRNA content for 5-LOX and the DNA methyltransferases DNMT1 and DNMT3a. In young mice, the 5-LOX mRNA content was significantly greater in the heart compared to the brain; 5-LOX DNA methylation was lower, except in the AciI assay in which it was higher in the heart. Aging decreased 5-LOX mRNA content in the heart and increased it in the brain. Aging also increased 5-LOX DNA methylation and this effect was site-(i.e., enzyme) and tissue-specific. Generally, DNMT1 and DNMT3a mRNA content was lower in the brain regions compared to the heart; the only effect of aging was observed in the mRNA content of DNMT3a, which was decreased in the heart of old mice. These results indicate a complex tissue-specific and aging-dependent interplay between the DNA methylation system and 5-LOX mRNA content. Interpretation of this data must take into account that the tissue samples contained a mixture of various cell types. Copyright (C) 2009 Svetlana Dzitoyeva et al.
引用
收藏
页数:9
相关论文
共 46 条
[1]   Augmentation of myocardial production of 15-epi-lipoxin-A4 by pioglitazone and atorvastatin in the rat [J].
Birnbaum, Yochai ;
Ye, Yumei ;
Lin, Yu ;
Freeberg, Sheldon Y. ;
Nishi, Shawn P. ;
Martinez, Juan D. ;
Huang, Ming-He ;
Uretsky, Barry F. ;
Perez-Polo, Jose R. .
CIRCULATION, 2006, 114 (09) :929-935
[2]  
Chabot C, 1998, HIPPOCAMPUS, V8, P299, DOI 10.1002/(SICI)1098-1063(1998)8:3<299::AID-HIPO11>3.0.CO
[3]  
2-W
[4]   The 5-lipoxygenase enzymatic pathway in the mouse brain:: Young versus old [J].
Chinnici, Cinzia M. ;
Yao, Yuemang ;
Pratico, Domenico .
NEUROBIOLOGY OF AGING, 2007, 28 (09) :1457-1462
[5]  
Chu Jin, 2009, Cardiovasc Psychiatry Neurol, V2009, P174657, DOI 10.1155/2009/174657
[6]  
Costa E, 2007, EPIGENETICS-US, V2, P29
[7]   Leukotriene pathway genetics and pharmacogenetics in allergy [J].
Duroudier, N. P. ;
Tulah, A. S. ;
Sayers, I. .
ALLERGY, 2009, 64 (06) :823-839
[8]   What's all the FLAP about?: 5-lipoxygenase-activating protein inhibitors for inflammatory diseases [J].
Evans, Jilly F. ;
Ferguson, Andrew D. ;
Mosley, Ralph T. ;
Hutchinson, John H. .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2008, 29 (02) :72-78
[9]   Transcellular biosynthesis of cysteinyl leukotrienes in rat neuronal and glial cells [J].
Farias, Santiago E. ;
Zarini, Simona ;
Precht, Thomas ;
Murphy, Robert C. ;
Heidenreich, Kim A. .
JOURNAL OF NEUROCHEMISTRY, 2007, 103 (04) :1310-1318
[10]   Cardiac remodelling hinders activation of cyclooxygenase-2, diminishing protection by delayed pharmacological preconditioning:: role of HIF1α and CREB [J].
Feng, Jianhua ;
Lucchinetti, Eliana ;
Fischer, Gregor ;
Zhu, Min ;
Zaugg, Kathrin ;
Schaub, Marcus C. ;
Zaugg, Michael .
CARDIOVASCULAR RESEARCH, 2008, 78 (01) :98-107